Malignant Ovarian Neoplasm — Trials

Malignant Ovarian Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,086 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 684
Recruiting: 385
Ph III recruiting: 46
Growth YoY: +9.8%
Industry share: 37%
Top sponsor: National Cancer Institute (NCI)
Termination share: 32.8%
Trials / 1,000 deaths: 53.1 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (437)

clinicaltrialsPublishedShowing 101–150 of 292 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06580002	Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial	recruiting	Phase 2	75	University of California, IrvineOTHER	1	Jul 14, 2026	clinicaltrials
NCT05000294	Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types	recruiting	Phase 1 / Phase 2	29	University of FloridaOTHER	1	Jul 13, 2026	clinicaltrials